EP News Bureau

Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action

Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…

The parties will seek dismissal of the pending LEQSELVI litigation in the United States District Court for the District of New…

Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…

The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…

Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…

IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…

Pfizer and Astellas Pharma has announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK…

Lupin and a pan-European pharmaceutical company, Zentiva have entered into a license and supply agreement for commercialisation of…